Physician profile
Andrew S Tanner
NPI 1679501456
$1,728.75
in general payments reported to CMS, 2019-2025
28 companies · $31.46 in 2025
The $31.46 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $297 · 2021: $455 · 2022: $381 · 2023: $295 · 2024: $65.10 · 2025: $31.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $391.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $201.62 | 2020-2022 | |
| Daiichi Sankyo INC. | $158.43 | 2019-2021 | |
| Visionrt, INC. | $126.68 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $108.01 | 2020-2022 | |
| Janssen Biotech, INC. | $105.36 | 2021-2023 | Erleada |
| Siemens Medical Solutions USA, INC. | $97.67 | 2021-2025 | Truebeam |
| Novocure INC. | $95.47 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $89.30 | 2020-2024 | |
| Emd Serono, INC. | $79.43 | 2023 | Bavencio |
| Janssen Scientific Affairs, LLC | $76.97 | 2021-2023 | |
| Varian Medical Systems, INC. | $72.48 | 2020 | |
| Glaxosmithkline, LLC. | $62.43 | 2022-2023 | Zejula |
| Pharmacyclics LLC, An Abbvie Company | $60.86 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $47.28 | 2021-2023 | Libtayo |
| Myovant Sciences INC. | $40.59 | 2021-2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $35.15 | 2022 | |
| Monteris Medical Corporation | $31.28 | 2023 | Neuroblate |
| Novartis Pharmaceuticals Corporation | $31.15 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $26.59 | 2022 | |
| Gilead Sciences, INC. | $26.20 | 2022 | |
| Medtronic, INC. | $26.15 | 2023 | Osteocool Rf Ablation System |
| Abbvie INC. | $25.15 | 2022 | |
| Alexion Pharmaceuticals, INC. | $21.81 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.27 | 2022 | |
| Genentech USA, INC. | $18.11 | 2021 | |
| Sumitomo Pharma America, INC. | $16.62 | 2023 | Orgovyx |
| Tactile Systems Technology INC | $14.17 | 2024 | Entre Plus, Flexitouch Plus |
| Eisai INC. | $12.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Tanner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.